华纳药厂：撤回利多卡因凝胶贴膏药品注册申请

Core Viewpoint - Warner Pharmaceuticals (688799.SH) has voluntarily withdrawn its drug registration application for Lidocaine Gel Patch, which is primarily used for alleviating postherpetic neuralgia without broken skin, as per the approval from the National Medical Products Administration [1] Group 1 - The company received a termination notice for the drug registration application from the National Medical Products Administration [1] - The application for the Lidocaine Gel Patch was submitted in March 2025 and was accepted, but the company decided to withdraw it after careful consideration of its R&D strategy [1] - The withdrawal of the drug registration application will not have a significant impact on the company's current and future operations and performance [1]